2025
The Abundance of Available Precursor Cells Can Drive Pediatric Cancer Incidence: Insights From an Algebraic Model.
Archives of pathology & laboratory medicine
PubMed • Publisher's siteResearch at a glance
Top areas of exploration
- MEF2 Transcription Factors , 6 publications
- Myogenic Regulatory Factors , 6 publications
- Neoplasms , 5 publications
- Oncogene Proteins, Fusion , 5 publications
Research activity
My publications
Filter publications
59 publications
2025
MAPT Splicing Modulators as a Therapeutic Strategy for Tauopathies.
bioRxiv : the preprint server for biology
PubMed • Publisher's site2023
Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group
Cancer
PubMed • Publisher's site2022
A Comprehensive Approach to the Management of Patients With HLHS and Related Malformations: An Analysis of 83 Patients (2015-2021).
World journal for pediatric & congenital heart surgery
PubMed • Publisher's site2021
Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low-risk clinical trials: A report from the Children's Oncology Group.
Pediatric blood & cancer
PubMed • Publisher's site